Criticality of the Biological and Physical Stimuli Array Inducing Resident Cardiac Stem Cell Determination

The replacement of injured cardiac contractile cells with stem cell‐derived functionally efficient cardiomyocytes has been envisaged as the resolutive treatment for degenerative heart diseases. Nevertheless, many technical issues concerning the optimal procedures to differentiate and engraft stem cells remain to be answered before heart cell therapy could be routinely used in clinical practice. So far, most studies have been focused on evaluating the differentiative potential of different growth factors without considering that only the synergistic cooperation of biochemical, topographic, chemical, and physical factors could induce stem cells to adopt the desired phenotype. The present study demonstrates that the differentiation of cardiac progenitor cells to cardiomyocytes does not occur when cells are challenged with soluble growth factors alone, but requires strictly controlled procedures for the isolation of a progenitor cell population and the artifactual recreation of a microenvironment critically featured by a fine‐tuned combination of specific biological and physical factors. Indeed, the scaffold geometry and stiffness are crucial in enhancing growth factor differentiative effects on progenitor cells. The exploitation of this concept could be essential in setting up suitable procedures to fabricate functionally efficient engineered tissues.

[1]  R Langer,et al.  Tissue engineering by cell transplantation using degradable polymer substrates. , 1991, Journal of biomechanical engineering.

[2]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[3]  H R Allcock,et al.  Design of synthetic polymeric structures for cell transplantation and tissue engineering. , 1993, Clinical materials.

[4]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[5]  Charles A. Vacanti,et al.  Transplantation of Chondrocytes Utilizing a Polymer‐Cell Construct to Produce Tissue‐Engineered Cartilage in the Shape of a Human Ear , 1997, Plastic and reconstructive surgery.

[6]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[7]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[8]  E. Voest,et al.  Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment. , 2000, Molecular pharmacology.

[9]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[10]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[11]  L. Field,et al.  Cardiomyocyte cell cycle regulation. , 2002, Circulation research.

[12]  A Ahluwalia,et al.  Microsyringe-based deposition of two-dimensional and three-dimensional polymer scaffolds with a well-defined geometry for application to tissue engineering. , 2002, Tissue engineering.

[13]  R. Kirsner,et al.  Modulating Diseased Skin with Tissue Engineering: Actinic Purpura Treated with Apligraf , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[14]  P. Menasché Cell transplantation in myocardium. , 2003, The Annals of thoracic surgery.

[15]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Okano,et al.  Cell sheet engineering for myocardial tissue reconstruction. , 2003, Biomaterials.

[17]  Nadine Aubry,et al.  Aging increases stiffness of cardiac myocytes measured by atomic force microscopy nanoindentation. , 2003, American journal of physiology. Heart and circulatory physiology.

[18]  T. Okano,et al.  Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. , 2004, The New England journal of medicine.

[19]  Adam J. Engler,et al.  Myotubes differentiate optimally on substrates with tissue-like stiffness , 2004, The Journal of cell biology.

[20]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[21]  Thomas Eschenhagen,et al.  Engineered heart tissue for regeneration of diseased hearts. , 2004, Biomaterials.

[22]  S. Rafii,et al.  Platelet-Derived Growth Factor-AB Promotes the Generation of Adult Bone Marrow–Derived Cardiac Myocytes , 2004, Circulation research.

[23]  G. Forte,et al.  Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy , 2005, The Journal of pathology.

[24]  K. Woodhouse,et al.  Polyurethane films seeded with embryonic stem cell-derived cardiomyocytes for use in cardiac tissue engineering applications. , 2005, Biomaterials.

[25]  E. Tanaka,et al.  Multidifferentiation potential of mesenchymal stem cells in three-dimensional collagen gel cultures. , 2005, Journal of biomedical materials research. Part A.

[26]  D. Torella,et al.  Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival , 2005, Circulation research.

[27]  T. Feser,et al.  Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells Cultured onto Three Different Polymers In Vitro , 2005, Annals of Biomedical Engineering.

[28]  P. Menasché,et al.  Cell-based cardiac repair: reflections at the 10-year point. , 2005, Circulation.

[29]  T. Pedrazzini,et al.  FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. , 2005, The Journal of clinical investigation.

[30]  J. Leor,et al.  Cells, scaffolds, and molecules for myocardial tissue engineering. , 2005, Pharmacology & therapeutics.

[31]  J. García-Verdugo,et al.  Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? , 2006, Cardiovascular research.

[32]  D. Ingber,et al.  Cellular mechanotransduction: putting all the pieces together again , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  G. Forte,et al.  Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells: Proliferation, Migration, and Differentiation , 2006, Stem cells.

[34]  Ling Qin,et al.  Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. , 2006, Biomaterials.

[35]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[36]  Giovanni Vozzi,et al.  Characterization of tissue-engineered scaffolds microfabricated with PAM. , 2006, Tissue engineering.

[37]  S. Hsu,et al.  Evaluation of biodegradable polyesters modified by type II collagen and Arg-Gly-Asp as tissue engineering scaffolding materials for cartilage regeneration. , 2006, Artificial organs.

[38]  David J Mooney,et al.  Regulating myoblast phenotype through controlled gel stiffness and degradation. , 2007, Tissue engineering.

[39]  I. Hall,et al.  Cell adhesion and mechanical properties of a flexible scaffold for cardiac tissue engineering. , 2007, Acta biomaterialia.

[40]  D. Discher,et al.  Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery. , 2007, Advanced drug delivery reviews.

[41]  C. Schneider,et al.  Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). , 2007, Blood.